The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

C11203     (6R,7R)-7-[[2-(5-amino-1,2,4- thiadiazol-3...

Synonyms:
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of C11203

 

High impact information on C11203

 

Chemical compound and disease context of C11203

 

Biological context of C11203

 

Anatomical context of C11203

 

Associations of C11203 with other chemical compounds

 

Gene context of C11203

 

Analytical, diagnostic and therapeutic context of C11203

References

  1. In vitro activity of SCE-2787, a new cephalosporin with potent activity against Pseudomonas aeruginosa and members of the family Enterobacteriaceae. Klein, O., Chin, N.X., Huang, H.B., Neu, H.C. Antimicrob. Agents Chemother. (1994) [Pubmed]
  2. In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum. Iwahi, T., Okonogi, K., Yamazaki, T., Shiki, S., Kondo, M., Miyake, A., Imada, A. Antimicrob. Agents Chemother. (1992) [Pubmed]
  3. Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan. Muratani, T., Akasaka, S., Kobayashi, T., Yamada, Y., Inatomi, H., Takahashi, K., Matsumoto, T. Antimicrob. Agents Chemother. (2001) [Pubmed]
  4. Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa. Masuda, N., Sakagawa, E., Ohya, S. Antimicrob. Agents Chemother. (1995) [Pubmed]
  5. Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime. Paulfeuerborn, W., Müller, H.J., Borner, K., Koeppe, P., Lode, H. Antimicrob. Agents Chemother. (1993) [Pubmed]
  6. Comparative pharmacokinetics of SCE-2787 and related antibiotics in experimental animals. Kita, Y., Yamazaki, T., Imada, A. Antimicrob. Agents Chemother. (1992) [Pubmed]
  7. In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus. Toyokawa, M., Asari, S., Nishi, I., Horikawa, M., Tsukamoto, H., Sunada, A., Ueda, A., Iwatani, Y. Journal of chemotherapy (Florence, Italy) (2003) [Pubmed]
  8. Therapeutic effects of cefozopran against experimental mixed urinary tract infection with Enterococcus faecalis and Pseudomonas aeruginosa in mice. Tsuchimori, N., Yamazaki, T., Okonogi, K. J. Antimicrob. Chemother. (1997) [Pubmed]
  9. Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice. Iizawa, Y., Okonogi, K., Hayashi, R., Iwahi, T., Yamazaki, T., Imada, A. Antimicrob. Agents Chemother. (1993) [Pubmed]
  10. Antibacterial properties of SCE-2787, a new cephem antibiotic. Nakao, M., Noji, Y., Iwahi, T., Yamazaki, T. J. Antimicrob. Chemother. (1992) [Pubmed]
  11. Combination effect of SCE-2787 and cefepime with aminoglycosides on nosocomial gram-negative bacteria. Hübner, J., Hartung, D., Kropec, A., Daschner, F.D. Infection (1991) [Pubmed]
  12. The combination of aztreonam and cefozopran against Stenotrophomonas maltophilia. Kataoka, D., Tanaka, Y. J. Infect. Chemother. (2004) [Pubmed]
  13. Therapeutic effects of cefozopran on polymicrobial infections associated with Enterococcus faecalis in a Rat pyometra model. Mikamo, H., Kawazoe, K., Sato, Y., Izumi, K., Tamaya, T. Chemotherapy. (1998) [Pubmed]
  14. Development and validation of a MEKC method for the direct determination of cefozopran in human serum. Kitahashi, T., Furuta, I. Journal of pharmaceutical and biomedical analysis. (2004) [Pubmed]
 
WikiGenes - Universities